Prosecution Insights
Last updated: November 12, 2026
Application No. 18/413,133

COMPOSITION FOR INACTIVATION OF GRAM-POSITIVE BACTERIA AND BACTERIAL SPORES AND METHODS OF MAKING AND USING SAMECOMPOSITION FOR INACTIVATION OF GRAM-POSITIVE BACTERIA AND BACTERIAL SPORES AND METHODS OF MAKING AND USING SAME

Non-Final OA §DP
Filed
Jan 16, 2024
Priority
Jul 10, 2018 — provisional 62/695,867 +2 more
Examiner
LEBLANC, KATHERINE DEGUIRE
Art Unit
1791
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Resorcix Ltd.
OA Round
2 (Non-Final)
35%
Grant Probability
At Risk
2-3
OA Rounds
71%
With Interview

Examiner Intelligence

Grants only 35% of cases
35%
Career Allowance Rate
214 granted / 619 resolved
-30.4% vs TC avg
Strong +36% interview lift
Without
With
+36.0%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
36 currently pending
Career history
669
Total Applications
across all art units

Office Action

§DP
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 19,21,23-27,30-32,34,56-64 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 11-20 of U.S. Patent No. 11918013. Although the claims at issue are not identical, they are not patentably distinct from each other because Regarding claims 19,27,31,59,60, the ‘013 patent teaches(claim 11) “A beverage in a container, the beverage containing a composition wherein at least one of the following is true: (i) the composition comprises (a) crolechinic acid, hardwickiic acid, kolavenic acid, copalic acid, and, optionally, 7-alpha-acetoxyhardwickiic acid, and (b) beta-caryophyllene, the ratio of said crolechinic acid, hardwickiic acid, kolavenic acid, copalic acid, and 7-alpha-acetoxyhardwickiic acid if present, taken together, to said beta-caryophyllene being at least 1.1:1 by weight; (ii) the composition has been prepared by extracting Copaifera resin with a mixture of water and ethanol, whereby to obtain an upper fraction and lower fraction, and collecting the upper fraction obtained from the extraction to obtain the composition.” It would have been obvious to make the beverage by adding compounds (a) and (b) to a beverage such as water. Regarding claims 21,63,64 the ‘013 patent teaches(claim 12) “wherein the beverage has a turbidity of not more than 5 Nephelometric Turbidity Units (NTU), not more than 4 NTU, not more than 3 NTU, not more than 2 NTU, or not more than 1 NTU, as measured in accordance with the United States Environmental Protection Agency Method no. 180.1, published August 1993.” Regarding claims 23,24,32,57,58, the ‘013 patent teaches(claim 13) “The beverage of claim 11, wherein the composition is present in the beverage (a) at concentration of at least 1.25 microgram composition per ml beverage, and/or (b) a concentration of not more than 5.0 microgram composition per ml beverage.” Regarding claims 25,26,34,56, the ‘013 patent teaches(claim 17) “wherein the beverage is acidic and/or a fruit juice, optionally selected from the group consisting of apple juice, grape juice, peach juice, and watermelon juice. These juices are known to have an acidic pH of 3 to 6.” Regarding claims 30,61,62, the ‘013 patent teaches “wherein the composition is active against spores of Alicyclobacillus acidoterrestris”(claim 7, inventive concept 71). Response to Arguments The previous 102 and 103 rejections are withdrawn due to applicant’s incorporation of allowable claim limitations. However, please see the double patenting rejection as stated above. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KATHERINE D LEBLANC whose telephone number is (571)270-1136. The examiner can normally be reached 8AM-4PM EST M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Nikki Dees can be reached at 571-270-3435. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KATHERINE D LEBLANC/Primary Examiner, Art Unit 1791
Read full office action

Prosecution Timeline

Jan 16, 2024
Application Filed
Sep 26, 2024
Non-Final Rejection mailed — §DP
Mar 28, 2025
Response after Non-Final Action
Jul 31, 2026
Response Filed
Oct 02, 2026
Non-Final Rejection mailed — §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12773000
VEGETABLE FIBRE HYDROYSATE AND ITS USE IN HUMAN AND ANIMAL DIET
3y 10m to grant Granted Oct 27, 2026
Patent 12765574
PROTEIN HYDROLYSATE DERIVED FROM BLUE-BACKED FISH
4y 8m to grant Granted Oct 20, 2026
Patent 12729247
INHIBITED POROUS GRANULAR STARCHES AND METHODS OF MAKING AND USING THEM
3y 11m to grant Granted Sep 08, 2026
Patent 12721366
MEDIUM/LOW GLYCAEMIC INDEX PRODUCTS AND METHODS
6y 1m to grant Granted Sep 01, 2026
Patent 12703843
METHOD AND SYSTEM FOR THE FILTRATION AND STABILIZATION OF ULTRA-HIGH GRAVITY ALCOHOLIC BEVERAGES
4y 10m to grant Granted Aug 11, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
35%
Grant Probability
71%
With Interview (+36.0%)
Moderate
PTA Risk
Based on 619 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month